Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03091792

Ligand	Ligand name	Chain	PDB	Tanimoto
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.79
RCL	RICINOLEIC ACID	A	2CM4	0.74
RCL	RICINOLEIC ACID	A	2CM9	0.74
RCL	RICINOLEIC ACID	A	1FK7	0.74
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.81
6OB	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	A,B	2VV4	0.75
MPG	1-MONOOLEOYL-RAC-GLYCEROL	A	2GUF	0.71
MPG	1-MONOOLEOYL-RAC-GLYCEROL	A,B	1E12	0.71
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.78
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.73
9OH	(TRANS-12,13-EPOXY)-9-HYDROXY-10(E)-OCTADECENOIC ACID	A	1IK3	0.72
OLC	(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate	A	3D4S	0.75
11O	(TRANS-12,13-EPOXY)-11-HYDROXY-9(Z)-OCTADECENOIC ACID	A	1IK3	0.72
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2C6H	0.71
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2CA0	0.71
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2CD8	0.71
PXI	4-{[4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2VZ7	0.71
6OC	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	A,B	2VV4	0.76
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.86
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.86
GMM	GLUCOSE MONOMYCOLATE	A	1UQS	0.74
T24	(9Z,11E,13S,15Z)-13-hydroxyoctadeca-9,11,15-trienoic acid	A,B	3DSI	0.71
EAH	(5S,7E,9E,11Z,14Z)-5-hydroxyicosa-7,9,11,14-tetraenoic acid	A	3DZT	0.72
MVB	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	A,B,C	1YA8	0.8
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,B,E	1R8Q	0.71
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A	1RE0	0.71
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,E	1S9D	0.71
164	2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID	A	1R6W	0.8
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	1
PUL		A	2C78	0.73
MRC	MUPIROCIN	A	1JZS	0.73
MRC	MUPIROCIN	A,T	1FFY	0.73
MRC	MUPIROCIN	A	1QU3	0.73
MRC	MUPIROCIN	A,T	1QU2	0.73
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	2RCL	0.74
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	3DSK	0.74
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8P	0.74
DEB	6-DEOXYERYTHRONOLIDE B	A	1JIO	0.74
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8Q	0.74
DEB	6-DEOXYERYTHRONOLIDE B	A	1OXA	0.74
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8O	0.74
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.77
13T	13-DEOXYTEDANOLIDE	0,1,3,9,A,B,C,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	2OTJ	0.73
803	LOVASTATIN	A,B	1CQP	0.79
RGC	REIDISPONGIOLIDE C	A	2ASP	0.79
114	COMPACTIN	A,B,C,D	1HW8	0.79
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.79